2005 | 2004 | 2003 | 2002 | 2001

2004

November 19, 2004
Anti-Cancer Vaccine Licensed by Alteris Doubles Time-to-Disease Progression and Increases Survival in Phase I Brain Cancer Trial
> DOWNLOAD PDF
November 18, 2004
BioAdvance Names Dr. Michael Pellini as First Entrepreneur-In-Residence
> DOWNLOAD PDF
October 26 , 2004
Yaupon Therapeutics Initiates Clinical Trials for First Agent to Treat Epidemic of Methamphetamine Addiction
> DOWNLOAD PDF
October 19, 2004
BioAdvance Sponsors BioInformatics Alliance Retreat Highlighting
Critical Role of BioInformatics in 21st Century Drug Research.
> DOWNLOAD PDF
October 7, 2004
BioAdvance Portfolio Company Acuity Pharmaceuticals Leapfrogs From Seed Funding to Major Milestones.
> DOWNLOAD PDF
September 23, 2004
BioAdvance Ventures Announces Closing of $26 Million Early Stage Life Sciences Fund.
> DOWNLOAD PDF
July 22, 2004
Pennsylvania Bio Applauds Selection of Greenwood to Head BIO.
> DOWNLOAD PDF
July 8, 2004
BioAdvance Launches Third Investment Cycle.
> DOWNLOAD PDF
June 7, 2004
BioAdvance Organizes a Bio 2004 Panel on Regional Life Sciences Economic Development Efforts.
> DOWNLOAD PDF
April 19, 2004
BioAdvance Announces Acquisition of Greenhouse Recipient Gelifex By Leading Orthopedics Firm
> DOWNLOAD PDF
February 23, 2004
Cira Discovery Sciences and The Wistar Institute Announce Collaboration to Develop New Approaches to Proteomics-Based Diagnostics
> DOWNLOAD PDF
February 18, 2004
Alteris Licenses Rights from Duke And Johns Hopkins to Cancer Vaccine Targeting Variant EGF Receptor
> DOWNLOAD PDF
February 10, 2004
Acuity Pharmaceuticals Announces Completion of Financing Round
> DOWNLOAD PDF
February 10, 2004
BioAdvance Invests more than $3 Million in Regional Life Sciences Enterprises
> DOWNLOAD PDF